Literature DB >> 6933509

Elongation mechanism and substrate specificity of 2',5'-oligoadenylate synthetase.

J Justesen, D Ferbus, M N Thang.   

Abstract

2',5'-Oligoadenylate synthetase has been purified from a rabbit reticulocyte lysate to a high degree of purity. The enzyme contained no detectable interfering activities that could degrade the nucleoside triphosphate substrate or the oligomeric products. Two basic properties of this enzyme have been examined: the elongation mechanism for the synthesis of oligoadenylates and the substrate specificity for nucleotides. Kinetic studies on the formation of different oligomeric intermediates show that the dimer pppA2'p5'A is the first product to accumulate in predominant proportion during the first period of reaction; the trimer and other longer oligomers appear after a lag phase. The amount of the trimer increases at the expense of the dimer. Preformed dimers and trimers added to the incubation mixture were readily incorporated into higher oligomers, suggesting the free access of these dimers and trimers to the active center after the onset of polymerization of ATP. The results indicate clearly that the enzyme catalyzes the de novo synthesis of the oligonucleotide from ATP and that the mechanism of elongation of the 2',5'-oligonucleotides catalyzed by the enzyme is not processive. Polymerization of a mixture of ATP and another nucleoside triphosphate shows that the enzyme is not only an ATP polymerase. The 2',5'-oligoadenylate synthetase is in fact a 2',5'-nucleotidyltransferase that catalyzes the formation of co-oligonucleotides. However, the purified reticulocyte enzyme catalyzed only the addition of one unit of GMP, UMP, CMP, 2'-dAMP, 3'-dAMP, dCMP, dGMP, or TMP to the 2'-OH end of a preformed oligoadenylate. A procedure for the separation of 2',5'-oligonucleotides with or without the 5'triphosphate end also is described.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6933509      PMCID: PMC349896          DOI: 10.1073/pnas.77.8.4618

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells.

Authors:  A G Hovanessian; I M Kerr
Journal:  Eur J Biochem       Date:  1978-03

2.  Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.

Authors:  C Baglioni; M A Minks; P A Maroney
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

3.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

4.  Use of specific endonuclease cleavage in RNA sequencing.

Authors:  R C Gupta; K Randerath
Journal:  Nucleic Acids Res       Date:  1977-06       Impact factor: 16.971

5.  Model for the elongation of polynucleotide chains by polynucleotide phosphorylase.

Authors:  M N Thang; R A Harvey; M Grunberg-Manago
Journal:  J Mol Biol       Date:  1970-10-28       Impact factor: 5.469

6.  Kinetics of polymerization and phosphorolysis reactions of Escherichia coli polynucleotide phosphorylase. Evidence for multiple binding of polynucleotide in phosphorolysis.

Authors:  T Godefroy
Journal:  Eur J Biochem       Date:  1970-06

7.  Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.

Authors:  L Ratner; R C Wiegand; P J Farrell; G C Sen; B Cabrer; P Lengyel
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

8.  Ion-exchange thin-layer chromatography. XVI. Techniques for preparation and analysis of oligonucleotides.

Authors:  E Randerath; K Randerath
Journal:  J Chromatogr       Date:  1967-12

9.  Interferon-associated, dsRNA-dependent enzyme activities in a mutant 3T6 cell engaged in the semiconstitutive synthesis of interferon.

Authors:  A P Jarvis; C White; A Ball; S L Gupta; L Ratner; G C Sen; C Colby
Journal:  Cell       Date:  1978-08       Impact factor: 41.582

10.  Interferon action: isolation of nuclease F, a translation inhibitor activated by interferon-induced (2'-5') oligo-isoadenylate.

Authors:  A Schmidt; A Zilberstein; L Shulman; P Federman; H Berissi; M Revel
Journal:  FEBS Lett       Date:  1978-11-15       Impact factor: 4.124

View more
  9 in total

1.  Possible involvement of (2'5')oligoadenylate synthetase activity in pre-mRNA splicing.

Authors:  J Sperling; J Chebath; H Arad-Dann; D Offen; P Spann; R Lehrer; D Goldblatt; B Jolles; R Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  ELTA: Enzymatic Labeling of Terminal ADP-Ribose.

Authors:  Yoshinari Ando; Elad Elkayam; Robert Lyle McPherson; Morgan Dasovich; Shang-Jung Cheng; Jim Voorneveld; Dmitri V Filippov; Shao-En Ong; Leemor Joshua-Tor; Anthony K L Leung
Journal:  Mol Cell       Date:  2019-01-31       Impact factor: 17.970

3.  Lymphocytic 2',5'-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine.

Authors:  V Bonnevie-Nielsen; I Heron; T P Monath; C H Calisher
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

4.  (2'-5') Oligoadenylate synthetase in the maturation of rabbit reticulocytes.

Authors:  D Ferbus; J Justesen; H Bertrand; M N Thang
Journal:  Mol Cell Biochem       Date:  1984-04       Impact factor: 3.396

5.  Induction of (2'-5') oligoadenylate synthetase activity during granulocyte and monocyte differentiation.

Authors:  D Ferbus; U Testa; M Titeux; F Louache; M N Thang
Journal:  Mol Cell Biochem       Date:  1985-07       Impact factor: 3.396

6.  Structural requirements of (2'-5') oligoadenylate for protein synthesis inhibition in human fibroblasts.

Authors:  J L Drocourt; C W Dieffenbach; P O Ts'o; J Justesen; M N Thang
Journal:  Nucleic Acids Res       Date:  1982-03-25       Impact factor: 16.971

7.  The 2'-5'-oligoadenylate synthetase 3 enzyme potently synthesizes the 2'-5'-oligoadenylates required for RNase L activation.

Authors:  Mikkel Søes Ibsen; Hans Henrik Gad; Karthiga Thavachelvam; Thomas Boesen; Philippe Desprès; Rune Hartmann
Journal:  J Virol       Date:  2014-10-01       Impact factor: 5.103

8.  Natural occurrence of 2',5'-linked heteronucleotides in marine sponges.

Authors:  Annika Lopp; Tõnu Reintamm; Anne Kuusksalu; Indrek Tammiste; Arno Pihlak; Merike Kelve
Journal:  Mar Drugs       Date:  2010-02-02       Impact factor: 5.118

9.  Similar biological effects of different low doses of interferon alpha in cancer patients.

Authors:  C Billard; R A Diez; D Ferbus; N Raynaud; T Dorval; P Pouillart; K Nielsen; E Falcoff
Journal:  Br J Cancer       Date:  1987-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.